These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14171677)

  • 21. Studies with live attenuated measles-virus vaccine. Comparative clinical, antigenic, and prophylactic effects after inoculation with and without gamma-globulin.
    KRUGMAN S; GILES JP; JACOBS AM; FRIEDMAN H
    Am J Dis Child; 1962 Mar; 103():353-63. PubMed ID: 14459920
    [No Abstract]   [Full Text] [Related]  

  • 22. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

  • 23. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 24. [EXPERIENCE IN VACCINATION WITH ATTENUATED MEASLES VIRUS. 3. IMMUNOLOGIC AND EPIDEMIOLOGIC STUDY AFTER A YEAR OF OBSERVATION].
    HEVIA P; RODRIGUEZ M; UNDURRAGA O; ROSSELOT J; MENEGHELLO J
    Pediatria (Santiago); 1963; 6():151-6. PubMed ID: 14080014
    [No Abstract]   [Full Text] [Related]  

  • 25. [FURTHER OBSERVATIONS ON THE PROTECTIVE EFFECTS AND SEROLOGICAL RESPONSE IN CHILDREN IMMUNIZED WITH KILLED MEASLES VIRUS VACCINE].
    BRANCATO P; GULLO A; ALBANESE M
    Riv Ist Sieroter Ital; 1964; 39():287-92. PubMed ID: 14177289
    [No Abstract]   [Full Text] [Related]  

  • 26. A CONTROLLED TRIAL OF LIVER-VIRUS VACCINE AGAINST MEASLES IN CHILE.
    RISTORI C; BOCCARDO H; MIRANDA M; BORGONO M
    Bull World Health Organ; 1964; 30(6):763-8. PubMed ID: 14215183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A FOLLOW-UP STUDY OF IMMUNITY IN CHILDREN VACCINATED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    HALONEN P; FORSSELL P; BACKMAN A
    Arch Gesamte Virusforsch; 1965; 16():268-72. PubMed ID: 14322876
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 29. REACTIONS TO ATTENUATED MEASLES VIRUS VACCINE IN EVERYDAY PRACTICE.
    LEE HF
    GP; 1964 Apr; 29():132-3. PubMed ID: 14137556
    [No Abstract]   [Full Text] [Related]  

  • 30. MEASLES VACCINATION IN INFANTS. USE OF KILLED-LIVE COMBINATIONS.
    ALEXANDER ER; BANSMER CM; HARRIS ES; GILES B; SPARKS MJ
    Am J Dis Child; 1964 Nov; 108():470-8. PubMed ID: 14208407
    [No Abstract]   [Full Text] [Related]  

  • 31. STUDIES ON IMMUNITY TO MEASLES.
    KRUGMAN S; GILES JP; FRIEDMAN H; STONE S
    J Pediatr; 1965 Mar; 66():471-88. PubMed ID: 14264306
    [No Abstract]   [Full Text] [Related]  

  • 32. SUPPRESSION OF MEASLES 19S ANTIBODY FORMATION AS EVIDENCE OF IMMUNITY. PRIMARY IMMUNE RESPONSE MASKED BY MATERIAL ANTIBODY.
    SCHLUEDERBERG A; KARELITZ S
    JAMA; 1965 Mar; 191():1064-6. PubMed ID: 14267895
    [No Abstract]   [Full Text] [Related]  

  • 33. MEASLES VACCINATION.
    BUDAI J; FARKAS E; NYERGES G; CSAPO J
    Acta Paediatr Acad Sci Hung; 1964; 5():435-41. PubMed ID: 14236548
    [No Abstract]   [Full Text] [Related]  

  • 34. Live measles-virus vaccine: clinical trial of vaccine prepared from a variant of the Sugiyama strain adapted to bovine kidney cells.
    MATUMOTO M; MUTAI M; SABURI Y; FUJII R; MINAMITANI M; NAKAMURA K
    Jpn J Exp Med; 1962 Oct; 32():433-48. PubMed ID: 13933923
    [No Abstract]   [Full Text] [Related]  

  • 35. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
    MACLEOD DR
    Can Med Assoc J; 1964 Nov; 91(21):1118-22. PubMed ID: 14229761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
    Warren RJ; Nader PR; Levine RH
    JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
    [No Abstract]   [Full Text] [Related]  

  • 37. [VACCINATION AGAINST MEASLES WITH LIVE VIRUS FROM THE EDMONSTON STRAIN-NATIONAL EXPERIENCE].
    RISTORI C; BOCCARDO H; MIRANDA M; BORGONO M; STOCKEBRAND S; CANELLO J; MUNOZ S; CARRILLO B; CONCHA F; ASSAEL I; SANCHEZ L; OLIVARI I; ARAVENA M; BURTON S
    Rev Chil Pediatr; 1963 Aug; 34():656-63. PubMed ID: 14089202
    [No Abstract]   [Full Text] [Related]  

  • 38. Increasing attenuation of measles virus strain Sugiyama during serial passage in calf kidney cells.
    Kawana R; Kaneko M; Wako H; Iwai T; Kawana M
    Jpn J Exp Med; 1970 Aug; 40(4):257-63. PubMed ID: 5312395
    [No Abstract]   [Full Text] [Related]  

  • 39. CONTROLLED TRIAL OF LIVE MEASLES VACCINE. EFFECTS OF AGE, HISTORY OF MEASLES IN SIBLINGS, PREVACCINE ANTIBODY, AND HUMAN GAMMA-GLOBULIN ON SYMPTOMATIC AND IMMUNE RESPONSES.
    MARTIN CM; MANFREDONIA SJ; WEBB NC; MARKHAM FS; RUEGSEGGER JM
    Am J Dis Child; 1963 Sep; 106():267-79. PubMed ID: 14057606
    [No Abstract]   [Full Text] [Related]  

  • 40. [SIGNIFICANCE OF MEASLES. II].
    WESSELIUS-DECASPARIS A; VAN HERCK ; SOETERS GC; TEGELAERS WH
    Maandschr Kindergeneeskd; 1964 Mar; 32():85-100. PubMed ID: 14152671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.